Jan 18 (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los ...

During his time as a vaccine injury attorney, Kennedy launched complaints and lawsuits against Merck, the maker of Gardasil, which was first approved by the Food and Drug Administration in 2006.

Herbosa said that Filipino boys should also be inoculated with the HPV vaccine, saying that other countries have started immunizing boys after they diminished the number of their cervical cancer. Per ...

Merck has announced that its GARDASIL vaccine has received expanded approval for males in China, the first such indication in the country. New Jersey-based Merck, which does business outside of the ...

Senior Public Health Administrator Satish Bista revealed that 110,263 girls aged 10–14 from 11 local levels in Kathmandu district will receive the HPV vaccine. This includes 97,540 school-going ...

The human papillomavirus (HPV) vaccine has long been a key player in reducing the risks associated with various cancers. However, recent research has further underscored its unprecedented ...

Recent research has shed light on the wider impact of the HPV vaccine, offering protection against various other cancers, and certain health issues January marks Cervical Cancer Awareness Month, a ...

The recipient in Changsha, the capital of Hunan province, became the first man on the Chinese mainland to receive the HPV vaccine, after US pharmaceutical giant Merck announced its quadrivalent ...

The HPV vaccine, Gardasil, has gained approval for additional indications from China's National Medical Products Administration, becoming the first and only HPV vaccine authorized for use in men ...

Merck & Co's human papillomavirus (HPV) vaccine, Gardasil, has received approval from China's medical products administration for men aged 9-26 years. Gardasil, a key product for Merck alongside its ...

US pharmaceutical company Merck & Co said on Wednesday that its four-valent human papillomavirus vaccine has been approved for men aged 9 to 26 by China's top drug regulator. The vaccine that ...

U.S. drugmaker Merck & Co has received approval in China for its HPV vaccine's use in males, expanding its market reach despite earlier weak sales in the region. This move marks a potential growth ...